Valaciclovir or valacyclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C13H20N6O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier MZ1IW7Q79D, chemically known as valaciclovir, valtrex but more generally known as valaciclovir, which bears U.S. National Institutes of Health Compound Identifier 60773. The European Medicines Agency schedules Valaciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00003MIG. The term VALACICLOVIR is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 8 No. 3 1994, List 34). The World Health Organization schedules valaciclovir in its Anatomical Therapeutic Chemical (ATC) Classification. VALACICLOVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N.CL.